Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy

Journal of Dermatology

Volumn 37, Issue 12, 2010, Pages 1036-1039

  Thumpimukvatana, Narumol ^a   Wongpraparut, Chanisada ^a   Lim, Henry W ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

diabetes mellitus; phototherapy; scleredema; ultraviolet A1

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETIC RETINOPATHY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; PHOTOTHERAPY; RADIATION DOSE; SCLEREDEMA; SCLEREDEMA DIABETICORUM; SKIN BIOPSY; TREATMENT RESPONSE; ULTRAVIOLET IRRADIATION;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; RADIOTHERAPY DOSAGE; SCLEREDEMA ADULTORUM; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 78649684473     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01014.x     Document Type: Article

References (11)

1. Hager CM, Sobhi HA, Hunzelmann N, et al. Bath-PUVA therapy in three patients with scleredema adultorum. J Am Acad Dermatol 1998; 38: 240-242.
2. Tuchinda C, Kerr H, Taylor CR, et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed 2006; 22: 247-253.
3. Morita A, Kobayashi K, Isomura I, Tsuji T, Krutmann J,. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000; 43: 670-674.
4. Kerscher M, Dirschka T, Volkenandt M,. Treatment of localized scleroderma by UVA1 phototherapy. Lancet 1995; 346: 1166.
5. Kreuter A, Jansen T, Stucker M,. Low dose ultraviolet A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001; 26: 30-32.
6. Grundmann-Kollmann M, Behrens S, Gruss C, Gottlöber P, Peter RU, Kerscher M,. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol 2000; 42: 134-136.
7. Tran KT, Prather HB, Cockerell CJ, Jacobe H,. UV-A1 therapy for nephrogenic systemic fibrosis. Arch Dermatol 2009; 145: 1170-1174.
8. Janiga JJ, Ward DH, Lim HW,. UVA-1 as a treatment for scleredema. Photodermatol Photoimmunol Photomed 2004; 20: 210-211.
9. Eberlein-Konig B, Vogel M, Katzer K, et al. Success-ful UVA1 phototherapy in a patient with scleredema adultorum. J Eur Acad Dermatol Venereol 2005; 19: 203-204.
10. Kroft EB, De Jong EM,. Scleredema diabeticorum case series: successful treatment with UV-A1. Arch Dermatol 2008; 144: 947-948.
11. Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melano-competent skin. J Invest Dermatol 2010; 130: 2092-2097.